Ethics of Ancestry Testing in Cancer Clinical Research
Ancestry testing to determine the ancestral origins or populations of an individual is now easily accessible. It has been suggested that ancestry testing could be used as a surrogate for race in biomedical research. At this presentation, Drs. Adebowale A. Adeyemo and Sara Hull will describe the potential advantages and disadvantages of ancestry testing as a surrogate for race and discuss the ethics of adopting such a practice in cancer research.
This event sponsored by NCI’s Division of Cancer Control and Population Sciences’ (DCCPS) Epidemiology and Genomics Research Program and NCI’s Division of Cancer Treatment and Diagnosis’ (DCTD) Cancer Diagnosis Program. For more event information, view the website or contact Carol Weil at 240-276-5975 or Charlisse Caga-anan at 240-276-6738.
Dr. Adebowale A. Adeyemo is the deputy director for the Center for Research on Genomics and Global Health at the National Human Genome Research Institute (NHGRI).
Dr. Sara Hull is the section head of Ethics of Genetics and Emerging Technologies in the Department of Bioethics at the National Institutes of Health (NIH) Clinical Center.
- NCI Imaging Data Commons Hosts 2022 RSNA Session: Towards Transparency and Reproducibility in Imaging AINovember 27, 2022 - November 30, 2022DataViz + Cancer Micro Lab: Using Data Visualization and Interactive Experiences to Advance Immuno-OncologyDecember 01, 2022